Advances in Cytology and Small Biopsies

Overview

State-of-the-Art Diagnostic Pathology CME

You’ll gain knowledge, confidence, and experience through this unique series of online video CME lectures highlighting the integration of small biopsies, a common component of the typical FNAB procedure. Expert faculty from Harvard Medical School’s three academic centers — many of whom are leaders in the field — deliver a comprehensive tutorial on the current state of the art in cytology. Advances in Cytology and Small Biopsies continuing medical education topics including:

• Advances in automation and standardized terminology
• “Challenging Cases and Lessons Learned” case-based virtual microscopy sessions
• Urinary cytopathology and changes to The Paris System 2.0 last updated in 2022
• The role of the cytopathologist in diagnosis using minimally invasive techniques
• Updates on utilizing ancillary testing for diagnosis, prognosis, and targeted therapy
• And more!

Topics / Speakers

HSIL and Its Mimics - Vanda F. Torous, MD

Endocervical-AGCs and Worse - Vanda F. Torous, MD

Endometrial Cells and Their Mimics - Jeffrey Mito, MD, PhD

Questions and Answers - Jeffrey Mito, MD, PhD and Vanda F. Torous, MD

Primary HPV Screening for Cervical Cancer – Why and How - Sarah Feldman, MD, MPH

The Impact of Primary HPV Screening on the Cytology – Laboratory - Jeffrey Mito, MD, PhD

The Elusive Diagnosis of HSIL on the Anal Pap Test - Ivan Chebib, MD

Anal Dysplasia and Anal Cancer Prevention - Benjamin Davis, MD

Questions and Answers - Ivan Chebib, MD and Benjamin Davis, MD

Application of Practical Informatics to Cytology - Emilio Madrigal, DO

Compliance with CMS Billing - Stephen Black-Schaffer, MA, MD

Questions and Answers - Stephen Black-Schaffer, MD and Emilio Madrigal, DO

Challenging Cases and Lessons Learned – Virtual Microscopy 1 - Moderator: Emilio Madrigal, DO; Vanda F. Torous, MD, Caroline Hilburn, MD, and Jeffrey Mito, MD

Updates in Urine Cytology – Paris 2.0 - Eva M. Wojcik, MD

Malignant Effusions – Primary versus Metastatic - Marina Vivero, MD

Pulmonary Cytology – Workup of NSCLC on FNA and Small Biopsy - Paul VanderLaan, MD, PhD

Molecular Testing in Cytology Specimens - Lynette Sholl, MD

Questions and Answers - Paul VanderLaan, MD, PhD and Lynette Sholl, MD

WHO Reporting Systems in Cytopathology - Martha Bishop Pitman, MD

Soft Tissue FNA and Small Biopsy – Pt 1 - Ivan Chebib, MD

Soft Tissue FNA and Small Biopsy – Pt 2 - Vickie Jo, MD

Lymph Node FNA - Amy Ly, MD

Challenging Cases and Lessons Learned – Virtual Microscopy 2 - Moderator: Martha Bishop Pitman, MD; David H. Hwang, MD, Vickie Jo, MD, and Sanhong Yu, MBBS, PhD

The Milan System 2.0 and Salivary Gland FNA - William C. Faquin, MD, PhD

Unusual Tumors of the Head and Neck - Kristine Wong, MD

HPV Testing of Head and Neck Squamous Cell Carcinoma - William C. Faquin, MD, PhD

Questions and Answers - William C. Faquin, MD, PhD, and Kristine Wong, MD

Updates to the Bethesda System for Reporting Thyroid Cytopathology - Paul VanderLaan, MD, PhD

The Atypical Thyroid FNA – What’s AUS and What Isn’t - Edmund S. Cibas, MD

Questions and Answers - Edmund Cibas, MD, and Paul VanderLaan, MD, PhD

Molecular Testing in Thyroid FNA Specimens - Michiya Nishino, MD, PhD

Pancreatic Ductal Carcinoma - M. Lisa Zhang, MD

Pancreatic Non-Ductal Neoplasms - M. Lisa Zhang, MD

Pancreatic Cysts - Martha Bishop Pitman, MD

Questions and Answers - Martha Bishop Pitman, MD, and Lisa Zhang, MD

Challenges and Lessons Learned – Virtual Microscopy 3 - Moderator: Jeffrey Mito, MD, PhD; M. Lisa Zhang, MD, Kristine Wong, MD, Sarah J. Wu, MD, PhD, and Marina Vivero, MD

Faculty

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement

The Harvard Medical School designates this enduring material for a maximum of 23.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: July 31, 2023

Termination Date: July 30, 2026 (Please note that AMA PRA Category 1 Credits™ will no longer be issued for the activity after this date)
Estimated Time to Complete the Activity: 23.25 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

ACGME Competencies

This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:

• Practice-Based Learning and Improvement
• Systems-Based Practice
• Patient Care and Procedural Skills
• Medical Knowledge

Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Learning Objectives

Upon completion of this activity, participants will be able to:

• Recognize the full range of diagnostic approaches to cytological and small tissue samples from all body sites
• Evaluate current and potential applications of automated screening, liquid-based preparation methods, flow cytometry and molecular testing
• Assess the impact of new technologies on cytology practice
• Apply current standards for the evaluation and work-up of cytology and small tissue samples for diagnosis, prognosis and targeted therapy
• Summarize the new standardized terminology and reporting systems for gynecological, pancreaticobiliary, thyroid, salivary gland and urinary cytological specimens
• Identify diagnostic pitfalls and how to avoid them

Target Audience

Primary care physicians and specialty physicians.